Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 152684, 6 pages
http://dx.doi.org/10.1155/2013/152684
Research Article

Body Composition, Muscle Strength, and Physical Function of Patients with Bethlem Myopathy and Ullrich Congenital Muscular Dystrophy

1Department of Orthopaedics, Istituto Ortopedico Rizzoli, IRCCS, 40136 Bologna, Italy
2Department of Statistical Sciences, University of Bologna, 40126 Bologna, Italy
3Medicina Generale, Istituto Ortopedico Rizzoli, IRCCS, 40136 Bologna, Italy
4Direzione Sanitaria, Istituto Ortopedico Rizzoli, IRCCS, 40136 Bologna, Italy
5Department of Public Health Sciences, University of Modena and Reggio Emilia, 41122 Modena, Italy
6Laboratory of Musculoskeletal Cell Biology, Istituto Ortopedico Rizzoli, IRCCS, 40136 Bologna, Italy

Received 24 June 2013; Accepted 14 August 2013

Academic Editors: Y. K. Hayashi, G. Onder, L. Scorrano, and H. Topaloglu

Copyright © 2013 Maria Teresa Miscione et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. G. Bönnemann, “The collagen VI-related myopathies. Ullrich congenital muscular dystrophy and Bethlem myopathy,” Handbook of Clinical Neurology, vol. 101, pp. 81–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. P. C. Scacheri, E. M. Gillanders, S. H. Subramony et al., “Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype,” Neurology, vol. 58, no. 4, pp. 593–602, 2002. View at Google Scholar · View at Scopus
  3. L. Merlini, E. Martoni, P. Grumati et al., “Autosomal recessive myosclerosis myopathy is a collagen VI disorder,” Neurology, vol. 71, no. 16, pp. 1245–1253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Bethlem and G. K. Van Wijngaarden, “Benign myopathy, with autosomal dominant inheritance: a report on three pedigrees,” Brain, vol. 99, no. 1, pp. 91–100, 1976. View at Google Scholar · View at Scopus
  5. G. J. Jöbsis, J. M. Boers, P. G. Barth, and M. De Visser, “Bethlem myopathy: a slowly progressive congenital muscular dystrophy with contractures,” Brain, vol. 122, part 4, pp. 649–655, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Merlini, L. Morandi, C. Granata, and A. Ballestrazzi, “Bethlem myopathy: early-onset benign autosomal dominant myopathy with contractures. Description of two new families,” Neuromuscular Disorders, vol. 4, no. 5-6, pp. 503–511, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Pepe, E. Bertini, P. Bonaldo et al., “Bethlem myopathy (BETHLEM) and Ullrich scleroatonic muscular dystrophy: 100th ENMC International Workshop, 23-24 November 2001, Naarden, The Netherlands,” Neuromuscular Disorders, vol. 12, no. 10, pp. 984–993, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. Van Der Kooi, W. G. De Voogt, E. Bertini et al., “Cardiac and pulmonary investigations in Bethlem myopathy,” Archives of Neurology, vol. 63, no. 11, pp. 1617–1621, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Nadeau, M. Kinali, M. Main et al., “Natural history of Ullrich congenital muscular dystrophy,” Neurology, vol. 73, no. 1, pp. 25–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Briñas, P. Richard, S. Quijano-Roy et al., “Early onset collagen VI myopathies: genetic and clinical correlations,” Annals of Neurology, vol. 68, no. 4, pp. 511–520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Yonekawa, H. Komaki, M. Okada et al., “Rapidly progressive scoliosis and respiratory deterioration in Ullrich congenital muscular dystrophy,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 84, no. 9, pp. 982–988, 2013. View at Google Scholar
  12. “Health indicators for rare diseases: state of the art and future directions,” First Report. June 2008, http://www.eucerd.eu/?post_type=document&p=1207.
  13. L. Merlini and P. Bernardi, “Therapy of collagen VI-related myopathies (Bethlem and Ullrich),” Neurotherapeutics, vol. 5, no. 4, pp. 613–618, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. F. L. M. Norwood, C. Harling, P. F. Chinnery, M. Eagle, K. Bushby, and V. Straub, “Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population,” Brain, vol. 132, no. 11, pp. 3175–3186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. W. A. Irwin, N. Bergamin, P. Sabatelli et al., “Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency,” Nature Genetics, vol. 35, no. 4, pp. 367–371, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Angelin, T. Tiepolo, P. Sabatelli et al., “Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 3, pp. 991–996, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Merlini, P. Sabatelli, A. Armaroli et al., “Cyclosporine a in Ullrich congenital muscular dystrophy: long-term results,” Oxidative Medicine and Cellular Longevity, vol. 2011, Article ID 139194, 10 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Merlini, A. Angelin, T. Tiepolo et al., “Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 13, pp. 5225–5229, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Grumati, L. Coletto, P. Sabatelli et al., “Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration,” Nature Medicine, vol. 16, no. 11, pp. 1313–1320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Tolkovsky, “Autophagy thwarts muscle disease,” Nature Medicine, vol. 16, no. 11, pp. 1188–1190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. W. C. Chumlea, M. Cesari, W. J. Evans et al., “Sarcopenia: designing phase IIB trials,” Journal of Nutrition, Health and Aging, vol. 15, no. 6, pp. 450–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Grumati, L. Coletto, M. Sandri, and P. Bonaldo, “Autophagy induction rescues muscular dystrophy,” Autophagy, vol. 7, no. 4, pp. 426–428, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. “Low protein diet in patients with collagen VI related myopathies (LPD),” NCT01438788, 2011, http://clinicaltrials.gov.
  24. F. Gualandi, R. Curci, P. Sabatelli et al., “Macrophages: a minimally invasive tool for monitoring collagen VI myopathies,” Muscle and Nerve, vol. 44, no. 1, pp. 80–84, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Gualandi, A. Urciuolo, E. Martoni et al., “Autosomal recessive Bethlem myopathy,” Neurology, vol. 73, no. 22, pp. 1883–1891, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Lucioli, B. Giusti, E. Mercuri et al., “Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy,” Neurology, vol. 64, no. 11, pp. 1931–1937, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Pepe, B. Giusti, E. Bertini et al., “A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the α1(VI) collagen chain in an Italian family affected by Bethlem myopathy,” Biochemical and Biophysical Research Communications, vol. 258, no. 3, pp. 802–807, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Sabatelli, S. K. Gara, P. Grumati et al., “Expression of the collagen VI α5 and α6 Chains in normal human skin and in skin of patients with collagen VI-related myopathies,” Journal of Investigative Dermatology, vol. 131, no. 1, pp. 99–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Martoni, A. Urciuolo, P. Sabatelli et al., “Identification and characterization of novel collagen VI non-canonical splicing mutations causing ullrich congenital muscular dystrophy,” Human Mutation, vol. 30, no. 5, pp. E662–E672, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Sabatelli, E. Palma, A. Angelin et al., “Critical evaluation of the use of cell cultures for inclusion in clinical trials of patients affected by collagen VI myopathies,” Journal of Cellular Physiology, vol. 227, no. 7, pp. 2927–2935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. R. N. Baumgartner, S. J. Wayne, D. L. Waters, I. Janssen, D. Gallagher, and J. E. Morley, “Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly,” Obesity research, vol. 12, no. 12, pp. 1995–2004, 2004. View at Google Scholar · View at Scopus
  32. R. N. Baumgartner, K. M. Koehler, D. Gallagher et al., “Epidemiology of sarcopenia among the elderly in New Mexico,” American Journal of Epidemiology, vol. 147, no. 8, pp. 755–763, 1998. View at Google Scholar · View at Scopus
  33. WHO Organization, “Obesity: preventing and managing the global epidemic,” Tech. Rep., Geneva, Switzerland, 2000. View at Google Scholar
  34. A. Coin, G. Sergi, N. Minicuci et al., “Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20–80 year-old Italian population,” Clinical Nutrition, vol. 27, no. 1, pp. 87–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. R. J. O. Van Der Ploeg, V. Fidler, and H. J. G. H. Oosterhuis, “Hand-held myometry: reference values,” Journal of Neurology Neurosurgery and Psychiatry, vol. 54, no. 3, pp. 244–247, 1991. View at Google Scholar · View at Scopus
  36. L. Merlini, E. S. Mazzone, A. Solari, and L. Morandi, “Reliability of hand-held dynamometry in spinal muscular atrophy,” Muscle and Nerve, vol. 26, no. 1, pp. 64–70, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Merlini, E. Bertini, C. Minetti et al., “Motor function-muscle strength relationship in spinal muscular atrophy,” Muscle and Nerve, vol. 29, no. 4, pp. 548–552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Merlini, A. Solari, G. Vita et al., “Role of gabapentin in spinal muscular atrophy: results of a multicenter, randomized Italian study,” Journal of Child Neurology, vol. 18, no. 8, pp. 537–541, 2003. View at Google Scholar · View at Scopus
  39. W. W. Bryan, R. J. Hoagland, J. Murphy et al., “Can we eliminate placebo in ALS clinical trials?” Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 4, no. 1, pp. 11–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. E. A. C. Beenakker, J. H. Van der Hoeven, J. M. Fock, and N. M. Maurits, “Reference values of maximum isometric muscle force obtained in 270 children aged 4–16 years by hand-held dynamometry,” Neuromuscular Disorders, vol. 11, no. 5, pp. 441–446, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Chetta, A. Zanini, G. Pisi et al., “Reference values for the 6-min walk test in healthy subjects 20–50 years old,” Respiratory Medicine, vol. 100, no. 9, pp. 1573–1578, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. Z. Mei, L. M. Grummer-Strawn, A. Pietrobelli, A. Goulding, M. I. Goran, and W. H. Dietz, “Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents,” American Journal of Clinical Nutrition, vol. 75, no. 6, pp. 978–985, 2002. View at Google Scholar · View at Scopus
  43. J. S. Garrow and J. Webster, “Quetelet's index (W/H2) as a measure of fatness,” International Journal of Obesity, vol. 9, no. 2, pp. 147–153, 1985. View at Google Scholar · View at Scopus
  44. D. Gallagher, M. Visser, R. E. De Meersman et al., “Appendicular skeletal muscle mass: effects of age, gender, and ethnicity,” Journal of Applied Physiology, vol. 83, no. 1, pp. 229–239, 1997. View at Google Scholar · View at Scopus
  45. F. Kanda, Y. Fujii, K. Takahashi, and T. Fujita, “Dual-energy X-ray absorptiometry in neuromuscular diseases,” Muscle and Nerve, vol. 17, no. 4, pp. 431–435, 1994. View at Google Scholar · View at Scopus
  46. G. M. Palmieri, T. E. Bertorini, J. W. Griffin, M. Igarashi, and J. G. Karas, “Assessment of whole body composition with dual energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of lean body mass with muscle function,” Muscle Nerve, vol. 19, no. 6, pp. 777–779, 1996. View at Google Scholar
  47. V. Philippe, L. Pruna, M. Abdel Fattah, V. Pascal, and P. Kaminsky, “Decreased bone mineral density in adult patients with muscular dystrophy,” Joint Bone Spine, vol. 78, no. 6, pp. 647–654, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Pruna, J. Chatelin, V. Pascal-Vigneron, and P. Kaminsky, “Regional body composition and functional impairment in patients with myotonic dystrophy,” Muscle and Nerve, vol. 44, no. 4, pp. 503–508, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Allamand, L. Merlini, and K. Bushby, “166th ENMC International Workshop on Collagen type VI-related Myopathies, 22–24 May 2009, Naarden, The Netherlands,” Neuromuscular Disorders, vol. 20, no. 5, pp. 346–354, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. L. J. Hébert, J.-F. Remec, J. Saulnier, C. Vial, and J. Puymirat, “The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study,” BMC Musculoskeletal Disorders, vol. 11, article 72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. M. C. Walter, P. Reilich, S. Thiele et al. et al., “Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial,” Orphanet Journal of Rare Diseases, vol. 8, no. 1, article 26, 2013. View at Google Scholar
  52. W. Huygens, M. A. Thomis, M. W. Peeters, R. F. Vlietinck, and G. P. Beunen, “Determinants and upper-limit heritabilities of skeletal muscle mass and strength,” Canadian Journal of Applied Physiology, vol. 29, no. 2, pp. 186–200, 2004. View at Google Scholar · View at Scopus
  53. J. D. Cook and D. S. Glass, “Strength evaluation in neuromuscular disease,” Neurologic Clinics, vol. 5, no. 1, pp. 101–123, 1987. View at Google Scholar · View at Scopus
  54. B. Camarri, P. R. Eastwood, N. M. Cecins, P. J. Thompson, and S. Jenkins, “Six minute walk distance in healthy subjects aged 55–75 years,” Respiratory Medicine, vol. 100, no. 4, pp. 658–665, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Troosters, R. Gosselink, and M. Decramer, “Six minute walking distance in healthy elderly subjects,” European Respiratory Journal, vol. 14, no. 2, pp. 270–274, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. V. Z. Dourado, M. C. Vidotto, and R. L. F. Guerra, “Reference equations for the performance of healthy adults on field walking tests,” Jornal Brasileiro de Pneumologia, vol. 37, no. 5, pp. 607–614, 2011. View at Publisher · View at Google Scholar · View at Scopus